• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米喷雾干燥作为一种用于制造可吸入非甾体抗炎药粉末的新技术。

Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders.

作者信息

Aquino Rita Patrizia, Stigliani Mariateresa, Del Gaudio Pasquale, Mencherini Teresa, Sansone Francesca, Russo Paola

机构信息

Department of Pharmacy, University of Salerno, Via Giovanni Paolo II, No. 132, 84084 Fisciano, Italy.

出版信息

ScientificWorldJournal. 2014;2014:838410. doi: 10.1155/2014/838410. Epub 2014 Dec 16.

DOI:10.1155/2014/838410
PMID:25580462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4279258/
Abstract

The aim of this research was to evaluate the potential of the nanospray drier as a novel apparatus for the manufacturing of a dry powder for inhalation containing ketoprofen lysinate, a nonsteroidal anti-inflammatory drug able to control the inflammation in cystic fibrosis patients. We produced several ketoprofen lysinate and leucine powder batches by means of nanospray dryer, studying the influence of process parameters on yield, particle properties (size distribution and morphology), and, mainly, aerodynamic properties of powders. Micronized particles were prepared from different hydroalcoholic solutions (alcohol content from 0 to 30% v/v) using ketoprofen in its lysine salt form and leucine as dispersibility enhancer in different ratios (from 5 to 15% w/w) with a total solid concentration ranging from 1 to 7% w/v. Results indicated that the spray head equipped with a 7 µm nozzle produced powders too big to be inhaled. The reduction of nozzle size from 7 to 4 µm led to smaller particles suitable for inhalation but, at the same time, caused a dramatic increase in process time. The selection of process variables, together with the nozzle pretreatment with a surfactant solution, allowed us to obtain a free flowing powder with satisfying aerosol performance, confirming the usefulness of the nanospray drier in the production of powder for inhalation.

摘要

本研究的目的是评估纳米喷雾干燥器作为一种新型设备用于制造含赖氨酸酮洛芬的吸入用干粉的潜力,赖氨酸酮洛芬是一种能够控制囊性纤维化患者炎症的非甾体抗炎药。我们通过纳米喷雾干燥器制备了几批赖氨酸酮洛芬和亮氨酸粉末,研究了工艺参数对产率、颗粒性质(粒度分布和形态)以及主要是粉末空气动力学性质的影响。使用赖氨酸盐形式的酮洛芬和亮氨酸作为分散性增强剂,以不同比例(5%至15% w/w),从不同的水醇溶液(酒精含量从0至30% v/v)制备微粉化颗粒,总固体浓度范围为1%至7% w/v。结果表明,配备7 µm喷嘴的喷头产生的粉末太大,无法吸入。将喷嘴尺寸从7 µm减小到4 µm导致产生适合吸入的较小颗粒,但同时导致工艺时间大幅增加。工艺变量的选择,以及用表面活性剂溶液对喷嘴进行预处理,使我们能够获得具有令人满意的气溶胶性能的自由流动粉末,证实了纳米喷雾干燥器在吸入用粉末生产中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/e372e85dfae0/TSWJ2014-838410.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/a0f6c17e9d18/TSWJ2014-838410.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/5abcc9c22d0f/TSWJ2014-838410.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/ca472c7291cf/TSWJ2014-838410.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/e372e85dfae0/TSWJ2014-838410.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/a0f6c17e9d18/TSWJ2014-838410.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/5abcc9c22d0f/TSWJ2014-838410.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/ca472c7291cf/TSWJ2014-838410.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd32/4279258/e372e85dfae0/TSWJ2014-838410.004.jpg

相似文献

1
Nanospray drying as a novel technique for the manufacturing of inhalable NSAID powders.纳米喷雾干燥作为一种用于制造可吸入非甾体抗炎药粉末的新技术。
ScientificWorldJournal. 2014;2014:838410. doi: 10.1155/2014/838410. Epub 2014 Dec 16.
2
Non-steroidal anti-inflammatory drug for pulmonary administration: design and investigation of ketoprofen lysinate fine dry powders.肺部给药剂型的非甾体抗炎药:赖氨酸酮洛芬精细干粉的设计与研究。
Int J Pharm. 2013 May 1;448(1):198-204. doi: 10.1016/j.ijpharm.2013.03.030. Epub 2013 Mar 23.
3
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.庆大霉素和亮氨酸干粉吸入剂:制剂参数、气溶胶性能和对 CuFi1 细胞的体外毒性。
Int J Pharm. 2012 Apr 15;426(1-2):100-107. doi: 10.1016/j.ijpharm.2012.01.026. Epub 2012 Jan 23.
4
Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.喷雾干燥法制备可吸入共无定形布地奈德-精氨酸干粉。
Int J Pharm. 2019 Jun 30;565:1-8. doi: 10.1016/j.ijpharm.2019.04.036. Epub 2019 Apr 15.
5
Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.先进喷雾干燥化疗 PEG 化磷脂粒子的特性及其在肺癌干粉吸入递药中的气溶胶分散性能。
Eur J Pharm Sci. 2013 Jul 16;49(4):699-711. doi: 10.1016/j.ejps.2013.05.012. Epub 2013 May 23.
6
Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.妥布霉素和阿奇霉素有机溶液先进喷雾干燥微粒/纳米微粒抗生素干粉用于肺部吸入气雾剂递送的物理化学表征和气溶胶分散性能
Eur J Pharm Sci. 2014 Feb 14;52:191-205. doi: 10.1016/j.ejps.2013.10.016. Epub 2013 Nov 9.
7
Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.万古霉素和克拉霉素多功能控释粒子的先进喷雾干燥设计、理化特性表征和干粉吸入气溶胶的气溶胶分散性能,用于靶向呼吸递药。
Int J Pharm. 2013 Oct 15;455(1-2):374-92. doi: 10.1016/j.ijpharm.2013.06.047. Epub 2013 Jun 29.
8
Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections.含噬菌体的喷雾干燥可吸入粉末治疗肺部感染。
J Pharm Sci. 2011 Dec;100(12):5197-205. doi: 10.1002/jps.22715. Epub 2011 Aug 23.
9
L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.L-亮氨酸作为一种辅料对高吸湿性喷雾干燥粉末体外雾化性能的防潮作用。
Eur J Pharm Biopharm. 2016 May;102:132-41. doi: 10.1016/j.ejpb.2016.02.010. Epub 2016 Mar 9.
10
D-leucine microparticles as an excipient to improve the aerosolization performances of dry powders for inhalation.D-亮氨酸微球作为辅料改善干粉吸入剂的气溶胶化性能。
Eur J Pharm Sci. 2019 Mar 15;130:54-64. doi: 10.1016/j.ejps.2019.01.018. Epub 2019 Jan 21.

引用本文的文献

1
A Novel Combined Dry Powder Inhaler Comprising Nanosized Ketoprofen-Embedded Mannitol-Coated Microparticles for Pulmonary Inflammations: Development, In Vitro-In Silico Characterization, and Cell Line Evaluation.一种新型组合式干粉吸入器,包含用于肺部炎症的纳米尺寸酮洛芬包埋甘露醇包衣微粒:研发、体外-计算机模拟表征及细胞系评估
Pharmaceuticals (Basel). 2024 Jan 7;17(1):75. doi: 10.3390/ph17010075.
2
Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration.一种新型用于肺部给药的乙酰水杨酸干粉的研发及药代动力学
Pharmaceutics. 2022 Dec 15;14(12):2819. doi: 10.3390/pharmaceutics14122819.
3

本文引用的文献

1
Nanospray technology for an in situ gelling nanoparticulate powder as a wound dressing.用于原位凝胶纳米颗粒粉末作为伤口敷料的纳米喷雾技术。
Int J Pharm. 2014 Oct 1;473(1-2):30-7. doi: 10.1016/j.ijpharm.2014.06.049. Epub 2014 Jun 27.
2
In situ forming antibacterial dextran blend hydrogel for wound dressing: SAA technology vs. spray drying.原位形成抗菌葡聚糖共混水凝胶用于伤口敷料:SAA 技术与喷雾干燥法的对比。
Carbohydr Polym. 2014 Jan 30;101:1216-24. doi: 10.1016/j.carbpol.2013.10.067. Epub 2013 Oct 26.
3
Pure insulin highly respirable powders for inhalation.
Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.
通过喷雾干燥法开发吡非尼酮改进型可吸入粉末制剂:体外特性及药代动力学分析
Pharm Res. 2016 Jun;33(6):1447-55. doi: 10.1007/s11095-016-1887-3. Epub 2016 Mar 14.
用于吸入的纯胰岛素高可吸入性粉末。
Eur J Pharm Sci. 2014 Jan 23;51:110-7. doi: 10.1016/j.ejps.2013.08.009. Epub 2013 Aug 24.
4
Use of a fundamental approach to spray-drying formulation design to facilitate the development of multi-component dry powder aerosols for respiratory drug delivery.采用一种基础方法进行喷雾干燥制剂设计,以促进用于呼吸道药物递送的多组分干粉气雾剂的开发。
Pharm Res. 2014 Feb;31(2):449-65. doi: 10.1007/s11095-013-1174-5. Epub 2013 Aug 23.
5
Non-steroidal anti-inflammatory drug for pulmonary administration: design and investigation of ketoprofen lysinate fine dry powders.肺部给药剂型的非甾体抗炎药:赖氨酸酮洛芬精细干粉的设计与研究。
Int J Pharm. 2013 May 1;448(1):198-204. doi: 10.1016/j.ijpharm.2013.03.030. Epub 2013 Mar 23.
6
Calpain inhibitor nanocrystals prepared using Nano Spray Dryer B-90.采用纳米喷雾干燥器 B-90 制备钙蛋白酶抑制剂纳米晶体。
Nanoscale Res Lett. 2012 Aug 4;7(1):436. doi: 10.1186/1556-276X-7-436.
7
Gentamicin and leucine inhalable powder: what about antipseudomonal activity and permeation through cystic fibrosis mucus?庆大霉素和亮氨酸吸入粉:其抗铜绿假单胞菌活性和穿过囊性纤维化黏液的渗透作用如何?
Int J Pharm. 2013 Jan 20;440(2):250-5. doi: 10.1016/j.ijpharm.2012.05.077. Epub 2012 Jun 7.
8
Particles and powders: tools of innovation for non-invasive drug administration.微粒和粉末:非侵入式药物给药创新工具。
J Control Release. 2012 Jul 20;161(2):693-702. doi: 10.1016/j.jconrel.2012.02.028. Epub 2012 Mar 4.
9
Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.庆大霉素和亮氨酸干粉吸入剂:制剂参数、气溶胶性能和对 CuFi1 细胞的体外毒性。
Int J Pharm. 2012 Apr 15;426(1-2):100-107. doi: 10.1016/j.ijpharm.2012.01.026. Epub 2012 Jan 23.
10
Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.新型喷雾干燥聚合物粒子用于控制肺部药物传递的特性研究。
J Control Release. 2012 Mar 10;158(2):329-35. doi: 10.1016/j.jconrel.2011.10.030. Epub 2011 Oct 29.